BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jackson GS, Burk-Rafel J, Edgeworth JA, Sicilia A, Abdilahi S, Korteweg J, Mackey J, Thomas C, Wang G, Schott JM, Mummery C, Chinnery PF, Mead S, Collinge J. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol 2014;71:421-8. [PMID: 24590363 DOI: 10.1001/jamaneurol.2013.6001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Leemans M. Prion diseases. Anaesthesia & Intensive Care Medicine 2022. [DOI: 10.1016/j.mpaic.2022.10.008] [Reference Citation Analysis]
2 Spencer BR, Saá PP. Transfusion transmission of parasites and prions. Rossi's Principles of Transfusion Medicine 2022. [DOI: 10.1002/9781119719809.ch45] [Reference Citation Analysis]
3 Ritchie DL, Peden AH, Barria MA. Variant CJD: Reflections a Quarter of a Century on. Pathogens 2021;10:1413. [PMID: 34832569 DOI: 10.3390/pathogens10111413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Concha-Marambio L, Chacon MA, Soto C. Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease. Emerg Infect Dis 2020;26:34-43. [PMID: 31855141 DOI: 10.3201/eid2601.181423] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
5 Ascari LM, Rocha SC, Gonçalves PB, Vieira TCRG, Cordeiro Y. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies. Front Bioeng Biotechnol 2020;8:585896. [PMID: 33195151 DOI: 10.3389/fbioe.2020.585896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Knight R. Clinical diagnosis of human prion disease. Prog Mol Biol Transl Sci 2020;175:1-18. [PMID: 32958229 DOI: 10.1016/bs.pmbts.2020.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Eraña H, Charco JM, González-Miranda E, García-Martínez S, López-Moreno R, Pérez-Castro MA, Díaz-Domínguez CM, García-Salvador A, Castilla J. Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules 2020;10:E469. [PMID: 32204429 DOI: 10.3390/biom10030469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Giaccone G, Moda F. PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease. Biomolecules 2020;10:E405. [PMID: 32151109 DOI: 10.3390/biom10030405] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Leemans M. Prion diseases. Anaesthesia & Intensive Care Medicine 2020;21:56-59. [DOI: 10.1016/j.mpaic.2019.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Hughes C, Dineen T, Woodward BJ. Screening for Infections Prior to Medically Assisted Reproduction. Textbook of Assisted Reproduction 2020. [DOI: 10.1007/978-981-15-2377-9_80] [Reference Citation Analysis]
11 Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion Diseases. Neurol Clin 2018;36:865-97. [PMID: 30366560 DOI: 10.1016/j.ncl.2018.07.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
12 Appleby BS, Rhoads DD, Mente K, Cohen ML. A Practical Primer on Prion Pathology. J Neuropathol Exp Neurol 2018;77:346-52. [PMID: 29608707 DOI: 10.1093/jnen/nly019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Son M, Kim H, Yeo I, Kim Y, Sohn A, Kim Y. Method Validation by CPTAC Guidelines for Multi-protein Marker Assays Using Multiple Reaction Monitoring-mass Spectrometry. Biotechnol Bioproc E 2019;24:343-58. [DOI: 10.1007/s12257-018-0454-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Thompson AGB, Mead SH. Review: Fluid biomarkers in the human prion diseases. Mol Cell Neurosci 2019;97:81-92. [PMID: 30529227 DOI: 10.1016/j.mcn.2018.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
15 Brandel JP, Knight R. Variant Creutzfeldt-Jakob disease. Handb Clin Neurol 2018;153:191-205. [PMID: 29887136 DOI: 10.1016/B978-0-444-63945-5.00011-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
16 Ntantos D, Aggelopoulos P, Kazis D, Dagklis IE, Bostantjopoulou S. Diagnostic challenge of non-specific visual symptoms: consideration of Heidenhain variant of Creutzfeldt-Jakob disease. Clin Exp Optom 2018;101:311-3. [PMID: 28921636 DOI: 10.1111/cxo.12604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Anderson D. Creutzfeldt-Jakob Disease: Considerations for Perioperative Care: 2.2 www.aornjournal.org/content/cme. AORN J 2018;107:305-20. [PMID: 29486073 DOI: 10.1002/aorn.12073] [Reference Citation Analysis]
18 Seed CR, Hewitt PE, Dodd RY, Houston F, Cervenakova L. Creutzfeldt-Jakob disease and blood transfusion safety. Vox Sang 2018;113:220-31. [DOI: 10.1111/vox.12631] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
19 Turner ML. Safety of blood, blood derivatives, and plasma-derived products. Human Prion Diseases. Elsevier; 2018. pp. 463-72. [DOI: 10.1016/b978-0-444-63945-5.00026-x] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Späth PJ. Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates. Antibody Therapy 2018. [DOI: 10.1007/978-3-319-68038-5_12] [Reference Citation Analysis]
21 Kovacs GG, Andreasson U, Liman V, Regelsberger G, Lutz MI, Danics K, Keller E, Zetterberg H, Blennow K. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort. Eur J Neurol 2017;24:1326-e77. [PMID: 28816001 DOI: 10.1111/ene.13389] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
22 Knight R. Infectious and Sporadic Prion Diseases. Prog Mol Biol Transl Sci 2017;150:293-318. [PMID: 28838665 DOI: 10.1016/bs.pmbts.2017.06.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
23 Luk C, Jones S, Thomas C, Fox NC, Mok TH, Mead S, Collinge J, Jackson GS. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine. JAMA Neurol 2016;73:1454-60. [PMID: 27699415 DOI: 10.1001/jamaneurol.2016.3733] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
24 Crowder LA, Schonberger LB, Dodd RY, Steele WR. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk. Transfusion 2017;57:1875-8. [PMID: 28444687 DOI: 10.1111/trf.14145] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
25 Brandner S, Jaunmuktane Z. Prion disease: experimental models and reality. Acta Neuropathol 2017;133:197-222. [PMID: 28084518 DOI: 10.1007/s00401-017-1670-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
26 Welch T, Pasternak J. Recent Advances in Neuroanesthesiology. Essentials of Neuroanesthesia 2017. [DOI: 10.1016/b978-0-12-805299-0.00056-7] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Bougard D, Brandel J, Belondrade M, Beringue V, Segarra C, Fleury H, Laplanche J, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-wirth C, Knight R, Will R, Tiberghien P, Hai k S, Coste J. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Science Translational Medicine 2016;8:370ra182-370ra182. [DOI: 10.1126/scitranslmed.aag1257] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 15.3] [Reference Citation Analysis]
28 Leemans M. Prion diseases. Anaesthesia & Intensive Care Medicine 2016;17:641-644. [DOI: 10.1016/j.mpaic.2016.09.011] [Reference Citation Analysis]
29 Talan J. An Assay Detects Sporadic Creutzfeldt-Jakob Disease in Urine. Neurology Today 2016;16:1,4-5. [DOI: 10.1097/01.nt.0000510769.18849.83] [Reference Citation Analysis]
30 Thackray AM, Andreoletti O, Bujdoso R. Bioassay of prion-infected blood plasma in PrP transgenic Drosophila. Biochem J 2016;473:4399-412. [PMID: 27733649 DOI: 10.1042/BCJ20160417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
31 Cervenakova L, Saá P, Yakovleva O, Vasilyeva I, de Castro J, Brown P, Dodd R. Are prions transported by plasma exosomes? Transfus Apher Sci 2016;55:70-83. [PMID: 27499183 DOI: 10.1016/j.transci.2016.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
32 Whiting P, Kerby J, Coffey P, da Cruz L, McKernan R. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic. Philos Trans R Soc Lond B Biol Sci 2015;370:20140375. [PMID: 26416684 DOI: 10.1098/rstb.2014.0375] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
33 Haley NJ, Siepker C, Walter WD, Thomsen BV, Greenlee JJ, Lehmkuhl AD, Richt JA. Antemortem Detection of Chronic Wasting Disease Prions in Nasal Brush Collections and Rectal Biopsy Specimens from White-Tailed Deer by Real-Time Quaking-Induced Conversion. J Clin Microbiol 2016;54:1108-16. [PMID: 26865693 DOI: 10.1128/JCM.02699-15] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
34 Kim MO, Geschwind MD. Clinical update of Jakob-Creutzfeldt disease. Curr Opin Neurol 2015;28:302-10. [PMID: 25923128 DOI: 10.1097/WCO.0000000000000197] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
35 Maheshwari A, Fischer M, Gambetti P, Parker A, Ram A, Soto C, Concha-Marambio L, Cohen Y, Belay ED, Maddox RA, Mead S, Goodman C, Kass JS, Schonberger LB, Hussein HM. Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis 2015;21:750-9. [PMID: 25897712 DOI: 10.3201/eid2105.142017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
36 Sawyer EB, Edgeworth JA, Thomas C, Collinge J, Jackson GS. Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease. Sci Rep 2015;5:17742. [PMID: 26631638 DOI: 10.1038/srep17742] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
37 Di Minno G, Perno CF, Tiede A, Navarro D, Canaro M, Güertler L, Ironside JW. Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders. Blood Rev 2016;30:35-48. [PMID: 26381318 DOI: 10.1016/j.blre.2015.07.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
38 Pasternak JJ, Lanier WL. Neuroanesthesiology Update. Journal of Neurosurgical Anesthesiology 2015;27:87-122. [DOI: 10.1097/ana.0000000000000167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
39 Abdel-haq H. Factors intrinsic and extrinsic to blood hamper the development of a routine blood test for human prion diseases. Journal of General Virology 2015;96:479-93. [DOI: 10.1099/vir.0.070979-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
40 Späth PJ, Granata G, La Marra F, Kuijpers TW, Quinti I. On the dark side of therapies with immunoglobulin concentrates: the adverse events. Front Immunol 2015;6:11. [PMID: 25699039 DOI: 10.3389/fimmu.2015.00011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
41 Hilton DA, Shivane AG. Neurodegenerative Disorders. Neuropathology Simplified 2015. [DOI: 10.1007/978-3-319-14605-8_12] [Reference Citation Analysis]
42 Vetrugno V, Puopolo M, Cardone F, Capozzoli F, Ladogana A, Pocchiari M. The future for treating Creutzfeldt–Jakob disease. Expert Opinion on Orphan Drugs 2014;3:57-74. [DOI: 10.1517/21678707.2015.994605] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
43 McDowell KL, Nag N, Franco Z, Bu M, Piccardo P, Cervenak J, Deslys JP, Comoy E, Asher DM, Gregori L. Blood reference materials from macaques infected with variant Creutzfeldt-Jakob disease agent. Transfusion 2015;55:405-12. [PMID: 25154296 DOI: 10.1111/trf.12841] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
44 Saá P, Yakovleva O, de Castro J, Vasilyeva I, De Paoli SH, Simak J, Cervenakova L. First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification. J Biol Chem 2014;289:29247-60. [PMID: 25157106 DOI: 10.1074/jbc.M114.589564] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
45 Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog 2014;10:e1004202. [PMID: 24945656 DOI: 10.1371/journal.ppat.1004202] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 10.0] [Reference Citation Analysis]